Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.

The Indian journal of medical research - 1 Sept 2019

de Oliveira Fabricio Ferreira, Berretta Juliana Marília, de Almeida Junior Guido Veiga, de Almeida Sandro Soares, Chen Elizabeth Suchi, Smith Marilia Cardoso, Bertolucci Paulo Henrique Ferreira

Abstract excerpt

Background & objectives: Neurodegeneration affects blood pressure variations, while renal function and cerebral perfusion are impaired by vascular risk factors. This study was aimed to estimate variations of measures of cardiovascular risk in Alzheimer's dementia by pharmacogenetic analyses of the effects of angiotensin-converting enzyme (ACE) inhibitors and statins. Methods: Consecutive patients were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Coronary Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Lipid Metabolism

Share to Liver X Receptors

Share to Pharmacogenomic Testing

Share to Receptors, LDL

Share to Renin-Angiotensin System

Source

Open in PubMed Open full text

Identifiers

PMID: 31719297
DOI: 10.4103/ijmr.IJMR_1209_17
PMCID: PMC6886147

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.PMID 31719297Read ↗

Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease.Semantic proximity Read ↗

Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia.Semantic proximity Read ↗

Pharmacogenetics of angiotensin modulators according to APOE-ϵ4 alleles and the ACE insertion/deletion polymorphism in Alzheimer's disease.Semantic proximity Read ↗

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization studySemantic proximity Read ↗

Genomics and phenotypic profiles in dementia: implications for pharmacological treatment.Semantic proximity Read ↗

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer's disease: a Mendelian randomization study.Semantic proximity Read ↗

Causal cardiovascular risk factors for dementia: insights from observational and genetic studies.Semantic proximity Read ↗

Association of statins use and genetic susceptibility with incidence of Alzheimer's diseaseSemantic proximity Read ↗

ABC Transporters, APOE, CYP46A1 and LRP1 Gene Polymorphisms as Markers of Dementia Development in Patients with HyperlipidemiaSemantic proximity Read ↗

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian Randomization studySemantic proximity Read ↗

Influence of pharmacogenetic factors on Alzheimer's disease therapeutics.Semantic proximity Read ↗

Association of antihypertensive drug target genes with alzheimer's disease: a mendelian randomization study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.